BRITTANY OLIVER
OVERLAND PARK, KS
Browse related groups: KS Dermavant Sciences, Inc. All categories
This page merges CMS profile IDs: 11307459, 11309359 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$8,642.65
- Category: General Payments
- Program years: PY2021–2024
- Record count: 155
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,444.54 across 68 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,444.54 | 68 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Dermavant Sciences, Inc. | $292.54 | 15 |
| ABBVIE INC. | $204.47 | 12 |
| Sensus Healthcare, Inc. | $165.29 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $92.98 | 5 |
| Galderma Laboratories, L.P. | $90.35 | 4 |
| ConvaTec Inc. | $87.87 | 4 |
| Incyte Corporation | $81.44 | 4 |
| ORGANOGENESIS INC. | $68.55 | 3 |
| Lilly USA, LLC | $57.65 | 3 |
| Amgen Inc. | $46.27 | 2 |
| Smith & Nephew, Inc. | $34.08 | 1 |
| LEO Pharma Inc. | $34.05 | 2 |
| Kerecis Limited | $26.64 | 2 |
| Almirall LLC | $22.91 | 1 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $22.79 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $19.89 | 1 |
| E.R. Squibb & Sons, L.L.C. | $16.95 | 1 |
| Verrica Pharmaceuticals Inc. | $16.62 | 1 |
| UCB, Inc. | $15.83 | 1 |
| GENZYME CORPORATION | $15.02 | 1 |
| Arcutis Biotherapeutics, Inc. | $13.79 | 1 |
| Organon LLC | $9.91 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $8.65 | 1 |
By program year
Records — PY2024 (68)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11307459, 11309359
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.